These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33988307)

  • 21. TCF3 gene rearrangements in pediatric B-cell acute lymphoblastic leukemia-A single center experience.
    Zerkalenkova E; Menchits Y; Borkovskaia A; Sokolova S; Soldatkina O; Mikhailova E; Popov A; Komkov A; Rumiantseva Y; Karachunskii A; Olshanskaya Y
    Int J Lab Hematol; 2023 Aug; 45(4):533-540. PubMed ID: 37058324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-B acute lymphoblastic leukaemia recurrent fusion, EP300-ZNF384, is associated with a distinct gene expression.
    McClure BJ; Heatley SL; Kok CH; Sadras T; An J; Hughes TP; Lock RB; Yeung D; Sutton R; White DL
    Br J Cancer; 2018 Apr; 118(7):1000-1004. PubMed ID: 29531323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ZNF384-Related Fusion Genes in Acute Lymphoblastic Leukemia.
    Zhu L; Bai W; Cheng Q; Fang J
    Cancer Control; 2023; 30():10732748231182787. PubMed ID: 37306722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukemia With
    Lin N; Yan X; Cai D; Wang L
    Front Oncol; 2021; 11():709036. PubMed ID: 34395283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel class of ZNF384 aberrations in acute leukemia.
    Zaliova M; Winkowska L; Stuchly J; Fiser K; Triska P; Zwyrtkova M; Hrusak O; Starkova J; Sramkova L; Stary J; Trka J; Zuna J
    Blood Adv; 2021 Nov; 5(21):4393-4397. PubMed ID: 34529760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel recurrent EP300-ZNF384 gene fusion in B-cell precursor acute lymphoblastic leukemia.
    Gocho Y; Kiyokawa N; Ichikawa H; Nakabayashi K; Osumi T; Ishibashi T; Ueno H; Terada K; Oboki K; Sakamoto H; Shioda Y; Imai M; Noguchi Y; Arakawa Y; Kojima Y; Toyama D; Hata K; Yoshida T; Matsumoto K; Kato M; Fukushima T; Koh K; Manabe A; Ohara A;
    Leukemia; 2015 Dec; 29(12):2445-8. PubMed ID: 25943178
    [No Abstract]   [Full Text] [Related]  

  • 27. Lineage switch from pro-B acute lymphoid leukemia to acute myeloid leukemia in a case with t(12;17)(p13;q11)/TAF15-ZNF384 rearrangement.
    Grammatico S; Vitale A; La Starza R; Gorello P; Angelosanto N; Negulici AD; De Propris MS; Nanni M; Meloni G; Mecucci C; Foà R
    Leuk Lymphoma; 2013 Aug; 54(8):1802-5. PubMed ID: 23206227
    [No Abstract]   [Full Text] [Related]  

  • 28. The Prognostic Significance of
    Qin YZ; Jiang Q; Xu LP; Wang Y; Jiang H; Dao FT; Chen WM; Zhao XS; Liu YR; Zhang XH; Liu KY; Huang XJ
    Front Oncol; 2021; 11():632532. PubMed ID: 33816270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interphase-FISH screening for eight common rearrangements in pediatric B-cell precursor acute lymphoblastic leukemia.
    Hutspardol S; Pakakasama S; Kanta K; Nuntakarn L; Anurathapan U; Sirachainan N; Songdej D; Sawangpanich R; Tiyasirichokchai R; Rerkamnuaychoke B; Hongeng S
    Int J Lab Hematol; 2013 Aug; 35(4):406-15. PubMed ID: 23190578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Philadelphia-Like Genetic Rearrangements in Adults With B-Cell ALL: Refractoriness to Chemotherapy and Response to Tyrosine Kinase Inhibitor in
    Senapati J; Jabbour E; Konopleva M; Short NJ; Tang G; Daver N; Kebriaei P; Kadia T; Pemmaraju N; Takahashi K; DiNardo C; Sasaki K; Borthakur G; Thakral B; Kanagal-Shamanna R; Patel K; Ravandi F; Roberts K; Mullighan C; Kantarjian H; Jain N
    JCO Precis Oncol; 2023 May; 7():e2200707. PubMed ID: 37196217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel three-way fusions among ZNF384, EWSR1 and EHMT1 genes in paediatric B cell precursor acute lymphoblastic leukaemia with translocations resembling Philadelphia chromosomes.
    Chen X; Wang F; Cao P; Zhang Y; Ma X; Liu M; Teng W; Yang J; Zhang J; Wang T; Liu H
    Br J Haematol; 2019 Nov; 187(3):e75-e79. PubMed ID: 31531845
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia.
    Corrente F; Bellesi S; Metafuni E; Puggioni PL; Marietti S; Ciminello AM; Za T; Sorà F; Fianchi L; Sica S; De Stefano V; Chiusolo P
    Cytometry B Clin Cytom; 2018 May; 94(3):468-476. PubMed ID: 29220871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic characterisation of childhood B-other-acute lymphoblastic leukaemia in UK patients by fluorescence in situ hybridisation and Multiplex Ligation-dependent Probe Amplification.
    Schwab CJ; Murdy D; Butler E; Enshaei A; Winterman E; Cranston RE; Ryan S; Barretta E; Hawking Z; Murray J; Antony G; Vora A; Moorman AV; Harrison CJ
    Br J Haematol; 2022 Feb; 196(3):753-763. PubMed ID: 34676543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Rare Case Report of B-Cell Acute Lymphoblastic Leukemia with EP300::ZNF384 Fusion Gene.
    Wu X; Yang X; Chen Y; Zhang Z; XinhongYang
    Clin Lab; 2024 Jun; 70(6):. PubMed ID: 38868890
    [No Abstract]   [Full Text] [Related]  

  • 35. EP300-ZNF384 transactivates IL3RA to promote the progression of B-cell acute lymphoblastic leukemia.
    Hou Z; Ren Y; Zhang X; Huang D; Yan F; Sun W; Zhang W; Zhang Q; Fu X; Lang Z; Chu C; Zou B; Gao B; Jin B; Kang Z; Liu Q; Yan J
    Cell Commun Signal; 2024 Apr; 22(1):211. PubMed ID: 38566191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working Group.
    Hirabayashi S; Butler ER; Ohki K; Kiyokawa N; Bergmann AK; Möricke A; Boer JM; Cavé H; Cazzaniga G; Yeoh AEJ; Sanada M; Imamura T; Inaba H; Mullighan C; Loh ML; Norén-Nyström U; Pastorczak A; Shih LY; Zaliova M; Pui CH; Haas OA; Harrison CJ; Moorman AV; Manabe A
    Leukemia; 2021 Nov; 35(11):3272-3277. PubMed ID: 33692463
    [No Abstract]   [Full Text] [Related]  

  • 37. Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemia.
    Oberley MJ; Gaynon PS; Bhojwani D; Pulsipher MA; Gardner RA; Hiemenz MC; Ji J; Han J; O'Gorman MRG; Wayne AS; Raca G
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27265. PubMed ID: 29797659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical application of whole transcriptome sequencing for the classification of patients with acute lymphoblastic leukemia.
    Walter W; Shahswar R; Stengel A; Meggendorfer M; Kern W; Haferlach T; Haferlach C
    BMC Cancer; 2021 Aug; 21(1):886. PubMed ID: 34340673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRD-Negative Remission Induced in EP300-ZNF384 Positive B-ALL Patients by Tandem CD19/CD22 CAR T-Cell Therapy Bridging to Allogeneic Stem Cell Transplantation.
    Zhang XY; Dai HP; Zhang L; Liu SN; Dai Y; Wu DP; Tang XW
    Onco Targets Ther; 2021; 14():5197-5204. PubMed ID: 34744437
    [No Abstract]   [Full Text] [Related]  

  • 40. EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications.
    Schwab C; Ryan SL; Chilton L; Elliott A; Murray J; Richardson S; Wragg C; Moppett J; Cummins M; Tunstall O; Parker CA; Saha V; Goulden N; Vora A; Moorman AV; Harrison CJ
    Blood; 2016 May; 127(18):2214-8. PubMed ID: 26872634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.